Breast Cancer Prevention Study: Are Healthy Women Put at Risk by Federally Funded Research? : Hearing Before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, Second Session, October 22, 1992
United States, United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee
U.S. Government Printing Office, 1994 - 272 páginas
Comentarios de la gente - Escribir un comentario
No encontramos ningún comentario en los lugares habituales.
Otras ediciones - Ver todas
addition adjuvant Administration Advisory answer approved asked associated believe benefits blood bone breast cancer breast cancer prevention cause centers Chairman changes clinical trials Committee concern consent form considered continue deaths developing developing breast cancer Director disease document dose drug early estrogen Evaluation evidence factors findings given going Health healthy women heart high risk human important incidence increased indicated individual informed consent initial involved known liver cancer major minority National Cancer NSABP occurred Oncology participants patients PAYNE percent physician placebo population possible potential premenopausal women prevention trial primary problems Project protocol questions rats receiving reduce reported risk safety says serious side effects significant statement subjects suggest taking tamoxifen tests Thank therapy toxicity treated treatment tumors understand University uterine cancer woman
Página 250 - Bartels. the administrative director of the Center for Biomedical Ethics at the University of Minnesota, outlined some of the concerns raised at an NIH/ELSI conference on genetic counseling in the United States.
Página 98 - My colleagues and I will be pleased to respond to your questions. [The prepared statement of Dr.
Página 5 - Committee, all witnesses before the committee will be sworn in. From time to time during the hearing, we will be inserting into the record, without objection, documents relevant to this matter. Before we begin, let me say to all of our witnesses that the full text of your written statements will be inserted in the hearing record.
Página 99 - Department of Health and Human Services before the Subcommittee on Human Resources and Intergovernmental Relations House Committee on Government Operations Representative Edolphus Towns, Chairman October 15, 1993 Statement of Dr.
Página 186 - NIH: the National Cancer Institute (NCI); the National Heart, Lung, and Blood Institute (NHLBI); the National Institute of Dental Research (NIDR); the National Institute of Diabetes and Digestive and Kidney Diseases...
Página 5 - Operations, all witnesses before the committee will be sworn in. From time to time during the hearing we will be inserting into the record, without objection, documents relevant to this matter. Before we begin, let me say to all of our witnesses that the full text of your written statements will be inserted into the hearing record.
Página 73 - A clinical trial to determine the worth of tamoxifen for preventing breast cancer.
Página 45 - American Public Health Association 1015 15th Street NW Washington, DC 20005 (202) 789-5600...